Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Foundation Medicine's FoundationOne; Vitalité Health's Cancer Panel

Premium

Foundation Medicine has released its expanded FoundationOne test to include the sequencing of 314 genes as well as promoter and intronic regions from 29 genes.


The Vitalité Health Network, in collaboration with the Atlantic Cancer Research Institute now offers a next-generation sequencing-based cancer panel, Cancer Hotspot v2 as well as a colon and lung cancer panel.

The colon and lung cancer panel analyzes 22 genes while the Cancer Hotspot v2 panel sequences 50 genes that are frequently mutated in a wide variety of cancer.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.